← FDA Drug Approvals (Drugs@FDA)

TRAVOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2019-12-20

Drug application

FDA Application #

ANDA210458

Application type

Abbreviated New Drug Application (Generic)

Brand name

TRAVOPROST

Generic name

TRAVOPROST OPHTHALMIC SOLUTION USP, 0.004%

Active ingredients

TRAVOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2019-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown